Early in the COVID-19 pandemic, only 1% of Black men with untreated nonmetastatic prostate cancer had their prostates partially or completely removed, compared with 26% of White men, reveals a multicenter study yesterday in JAMA Oncology.In spring 2020, much routine medical care was deferred to conserve resources and protect patients and providers from infection.
All specialties, including oncology, delayed nonemergency care during that time, the authors noted, although there were concerns that COVID-19 could widen health disparities.One in seven Black men develop prostate cancer, and they are more likely than White men to be diagnosed with advanced prostate cancer and die of the disease, according to the researchers.Led by researchers at